- $3.33m
- -$1.64m
- $2.38m
- 29
- 51
- 34
- 31
Annual income statement for Oblong, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 15.3 | 7.74 | 5.48 | 3.81 | 2.38 |
| Cost of Revenue | |||||
| Gross Profit | 8.05 | 2.72 | 1.55 | 0.911 | 0.331 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 22.3 | 17.1 | 27.5 | 8.3 | 6.58 |
| Operating Profit | -6.95 | -9.35 | -22 | -4.5 | -4.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.32 | -9.14 | -21.9 | -4.36 | -4.03 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.42 | -9.05 | -21.9 | -4.38 | -4.04 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.42 | -9.05 | -21.9 | -4.38 | -4.04 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.23 | -9.76 | -21.9 | -5.5 | -13.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -25.4 | -6.26 | -6.44 | -1 | -15.7 |